These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4570661)

  • 21. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
    Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
    Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer factor as a probe of the immune defect in lepromatous leprosy.
    Hastings RC
    Int J Lepr Other Mycobact Dis; 1977; 45(3):281-91. PubMed ID: 336558
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of cell mediated immune responses in untreated cases of leprosy.
    Talwar GP; Krishnan AD; Mehra VL; Blum EA; Pearson JM
    Clin Exp Immunol; 1972 Oct; 12(2):195-203. PubMed ID: 4567646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the macrophage in resistance to the leprosy bacillus.
    Krahenbuhl JL; Adams LB
    Immunol Ser; 1994; 60():281-302. PubMed ID: 8251574
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E; De Boer T; Zulianello L; Ottenhoff TH
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological aspects of leprosy--present status.
    Godal T
    Prog Allergy; 1978; 25():211-42. PubMed ID: 362429
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on cellular immunity in leprosy. I. Lysosomal enzymes.
    Avila JL; Convit J
    Int J Lepr Other Mycobact Dis; 1970; 38(4):359-64. PubMed ID: 4929372
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell mediated and humoral immunity in "reversal reactions".
    Barnetson RS; Bjune G; Pearson JM; Kronvall G
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):267-74. PubMed ID: 776863
    [No Abstract]   [Full Text] [Related]  

  • 31. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.
    Salgame PR; Birdi TJ; Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro.
    Nery JA; Sampaio EP; Galhardo MC; Perissé AR; Vieira LM; Salles AM; Sarno EN
    Indian J Lepr; 2000; 72(2):155-67. PubMed ID: 11008656
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J; Stoner GL; Belehu A
    Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):300-7. PubMed ID: 4948077
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction.
    Birdi TJ; Salgame PR; Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):178-82. PubMed ID: 6967461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic researches in leprosy. Diagnostic applications.
    Merklen FP; Cottenot F; Potier JC
    Int J Lepr Other Mycobact Dis; 1971; 39(2):565-73. PubMed ID: 4948090
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 40. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I; Singh R
    Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.